VKTX – viking therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

VKTX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/12

08:08 am

vktx

Rating for VKTX

Medium Report

Rating for VKTX

Report

10/29

07:06 am

vktx

Rating for VKTX

Low Report

Rating for VKTX

Report

10/29

05:21 am

vktx

Viking Therapeutics initiated with a Buy at Canaccord

Low Report

Viking Therapeutics initiated with a Buy at Canaccord

Report

10/25

07:13 am

vktx

Viking Therapeutics (NASDAQ:VKTX) was upgraded by analysts at B. Riley to a "strong-buy" rating.

Medium Report

Viking Therapeutics (NASDAQ:VKTX) was upgraded by analysts at B. Riley to a "strong-buy" rating.

Report

10/25

07:13 am

vktx

Viking Therapeutics (NASDAQ:VKTX) was upgraded by analysts at B. Riley to a "strong-buy" rating.

Medium Report

Viking Therapeutics (NASDAQ:VKTX) was upgraded by analysts at B. Riley to a "strong-buy" rating.

Report

10/24

09:26 am

vktx

Rating for VKTX

Low Report

Rating for VKTX

Report

10/23

09:13 am

vktx

Rating for VKTX

Low Report

Rating for VKTX

Report

10/23

09:13 am

vktx

Rating for VKTX

Low Report

Rating for VKTX

Report

10/23

09:08 am

vktx

Viking Therapeutics (NASDAQ:VKTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Low Report

Viking Therapeutics (NASDAQ:VKTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Report

10/23

09:08 am

vktx

Viking Therapeutics (NASDAQ:VKTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Low Report

Viking Therapeutics (NASDAQ:VKTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Report

9/29

10:44 am

vktx

Viking Therapeutics (NASDAQ:VKTX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $102.00 price target on the stock.

Low Report

Viking Therapeutics (NASDAQ:VKTX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $102.00 price target on the stock.

Report

9/22

11:02 am

vktx

Viking Therapeutics (NASDAQ:VKTX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $125.00 price target on the stock.

Low Report

Viking Therapeutics (NASDAQ:VKTX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $125.00 price target on the stock.

Report

9/22

10:24 am

vktx

Rating for VKTX

Low Report

Rating for VKTX

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.